Market for single-use rocking bioreactors expected to expand by 2030

The report forecasts that the global market for these bioreactors will grow at a compound annual growth rate (CAGR) of 3.9% from 2025 to 2030, reflecting the industry’s ongoing shift toward single-use technologies in bioprocessing.

Single-use rocking bioreactors offer significant advantages, including reduced contamination risk, cost-effective production, and enhanced flexibility for cell culture and fermentation processes. Additionally, they are quick to set up and easy to scale, making them a preferred choice in biomanufacturing.

Key market drivers

The report identifies several factors driving the demand for these bioreactors:

• Increasing need for scalable and efficient bioprocessing solutions.
• Accelerated timelines for bringing biopharmaceuticals to market.
• Growing focus on personalized medicine.

Technological innovations, including automation and integration with downstream processes, are further enhancing the functionality and performance of these bioreactors, boosting their adoption.

In 2022, the cell culture sector accounted for approximately 60% of the single-use rocking bioreactor market. The rising demand for biopharmaceuticals—such as therapeutic proteins and vaccines—is a key factor driving their use in cell culture applications.

Regional insights

The Americas lead the global market, benefiting from the presence of major bioreactor manufacturers. Meanwhile, the Asia-Pacific region is projected to experience the fastest growth during the forecast period, fueled by increasing investments in biotechnology, expanding biopharmaceutical production capacities, and the growing adoption of single-use technologies.

Key players

Prominent companies highlighted in the report include Thermo Fisher Scientific Inc., Sartorius AG, and Merck KGaA.